SHENZHEN, China, Dec 19, 2013 /PRNewswire/ -- Mindray Medical
International Limited ("Mindray", NYSE: MR), a leading developer,
manufacturer and marketer of medical devices worldwide, today
announced shareholder resolutions adopted at its annual general
meeting of shareholders held in Hong
Kong on December 17, 2013.
At the meeting, Mindray shareholders approved the re-election of
incumbent directors Joyce I-Yin Hsu and Wu Qiyao each to serve a
three-year term.
In addition, Mindray shareholders ratified the appointment of
PricewaterhouseCoopers as the Company's independent registered
public accounting firm for the fiscal year ending December 31, 2013.
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain our global headquarters
in Shenzhen, China, U.S. headquarters in Mahwah, New
Jersey and multiple sales offices in major international
markets. From our main manufacturing and engineering base
in China, we supply through our worldwide distribution network
a broad range of products across three primary business segments,
namely patient monitoring and life support, in-vitro diagnostic,
and medical imaging systems. For more information, please
visit http://ir.mindray.com.
For investor and media inquiries, please contact:
In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com
In the U.S.:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com
SOURCE Mindray Medical International Limited